Latest News Archive
Please select Category, Year, and then Month to display items
31 July 2020
|
Story Lacea Loader
As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the University of the Free State (UFS) will be presenting the 3rd UFS Thought-Leader Series in collaboration with Vrye Weekblad as part of the Vrystaat Literature Festival’s online initiative, VrySpraak-digitaal.
This year, higher-education institutions
globally are placed in the challenging context of COVID-19. Aware and grounded in the reality that the world will not return to the normality of pre-COVID-19, our responsibility as scholars still remains to contribute to public discourse and to offer
innovative solutions that will impact the lives of people nationally and globally in order to help them understand and adapt to a new world order.
Against this background and context, this year’s debates focus on ‘Post-COVID-19, Post-Crisis’,
with Health and Modelling, Politics, Economy, and Predictions for 2021 as the sub-themes. Placed in a COVID-19 context, and in lieu of the Vrystaat Arts Festival,
the series will be presented virtually in the form of one webinar per month during the period August 2020 to November 2020.
Date: 13 August 2020
Topic: Health
and Modelling
Time: 11:30-13:00
RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za
Facilitator:
Max du Preez
Editor: Vrye Weekblad
Biography
Introduction and welcome:
Prof Francis Petersen
Rector and Vice-Chancellor, UFS
Panellists:
Prof Salim Abdool Karim
Director: Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Chair: South African Ministerial Advisory Committee on COVID-19
Biography
Prof Glenda Gray
President and CEO: South African Medical Research Council (SAMRC)
Biography
Prof Felicity Burt
NRF-DST South African Research Chair in vector-borne and zoonotic pathogens research
Biography
New Division of Virology to deliver crucial services for HIV diagnosis and resistance testing
2015-12-14
The establishment of a Division of Virology within the Department of Medical Microbiology, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology. Dr Dominique Goedhals, Head of the Division, says the division will also provide training of undergraduate medical students, medical technologists and technicians, and registrars. |
The newly established Division of Virology at the University of the Free State will be one of only five laboratories in the country to be involved in crucial diagnostic and testing services for HIV viral load monitoring, early infant diagnosis, and HIV resistance testing.
The Virology Diagnostic Laboratory serves as the reference laboratory for all HIV National Priority Programme samples for the Free State and Northern Cape provinces.
Medical staff at the laboratory will provide a 24-hour consultative service, as well as outreach programmes to district laboratories in the Free State and Northern Cape where pathologists are not available.
Dr Dominique Goedhals, Head of the Division of Virology, says this division, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.
The division will not only deliver this critical diagnostic service, but will also focus on training and teaching, as well as research.
Teaching and training activities include teaching of undergraduate medical students, medical technologists and technicians, and registrars. The postgraduate science programme has a high output of honours, master’s and doctoral students in Virology. The intern medical scientist programme is also active, with five interns having successfully submitted their portfolios since the programme was implemented in 2010.
Research activities under the Head of Research, Prof Felicity Burt, have also expanded and continue to show increases in publication output and acquisition of grant funding. Established research groups within the Division of Virology focus on vector-borne and zoonotic viruses, human papilloma viruses (HPV), and human immunodeficiency virus (HIV), as well as work with a number of international collaborators.